Rosalind Franklin University Associate Professor Noah Rosenblatt, PhD, works with a study participant in the Center for Lower Extremity Ambulatory Research.
"Up to one-third of people living with diabetes will develop a diabetic foot ulcer within their lifetime," said Dr. Rosenblatt, who works within RFU's Center for Lower Extremity Ambulatory Research and also serves as associate dean of research for the Dr. William M. Scholl College of Podiatric Medicine. "Many of those will never heal and may require amputation. Our long-term goal is to optimize offloading adherence and subsequent DFU healing outcomes by considering not only how much the device offloads the DFU, but also how much the device's design impacts the patient experience."
Dr. Rosenblatt was also awarded a two-year, $349,999 grant from the Department of Defense's Orthotic and Prosthetic Outcome Research Program for a study of the physical and mental health of service members and veterans who use prosthetics.
"As warfighters injured during recent conflicts continue to age, they will be faced with new physical and mental challenges that impact mobility, including increased fall risk," Dr. Rosenblatt said. "We must support advances in rehabilitation across their lifespan."
Dr. Rosenblatt's team hopes to provide preliminary evidence that the socket trim line (how high the prosthetic socket comes up the leg) in people with transfemoral amputation can impact fall risk, and to ultimately promote enduring improvements in the physical and mental health of prosthetic users by reducing the prevalence and the burden of falls.
"Dr. Rosenblatt's innovative research deserves this federal investment," said RFU's Executive Vice President of Research Ronald Kaplan, PhD. "We hope it leads to improvements in the quality of life for these important patient groups."
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.